---
title: "Bayer Wins Legal Fight in Bid for $7.25 Billion Roundup Settlement Approval"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/290133172.md"
description: "Bayer AG won a legal fight that moves it closer to Missouri state court approval for a proposed $7.25 billion settlement covering thousands of US cancer lawsuits alleging its Roundup weedkiller caused cancer. According to Bloomberg, the ruling advances Bayer’s effort to resolve the litigation through the state court process."
datetime: "2026-06-18T02:58:52.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/290133172.md)
  - [en](https://longbridge.com/en/news/290133172.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/290133172.md)
generator: "portal-rs"
---

# Bayer Wins Legal Fight in Bid for $7.25 Billion Roundup Settlement Approval

Bayer AG won a legal fight that moves it closer to Missouri state court approval for a proposed $7.25 billion settlement covering thousands of US cancer lawsuits alleging its Roundup weedkiller caused cancer. According to Bloomberg, the ruling advances Bayer’s effort to resolve the litigation through the state court process.

### Related Stocks

- [BAYZF.US](https://longbridge.com/en/quote/BAYZF.US.md)
- [BAYN.DE](https://longbridge.com/en/quote/BAYN.DE.md)
- [BAYRY.US](https://longbridge.com/en/quote/BAYRY.US.md)

## Related News & Research

- [Weekly Recap: Eighth Circuit upholds Roundup and Kerendia Japan filing](https://longbridge.com/en/news/297465368.md)
- [BAYN: On track for above-market growth, margin expansion, and industry-leading innovation by 2029](https://longbridge.com/en/news/297795362.md)
- [U.S. court dismisses appeal over objections to $7.25 billion Roundup deal](https://longbridge.com/en/news/297228985.md)
- [Bayer says Crop Science unit makes progress on product launches](https://longbridge.com/en/news/297781754.md)
- [IBA to assess electron beam, Rhodotron technology for PFAS destruction under PFAROS initiative](https://longbridge.com/en/news/297733650.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**